Alpha Teknova (TKNO) Change in Receivables (2020 - 2026)
Alpha Teknova's (TKNO) quarterly Change in Receivables came in at $1.1 million in Q1 2026, down 21.35% year-on-year from $1.3 million in Q1 2025, and up 304.04% on a QoQ basis from -$520000.0 in Q4 2025.
Alpha Teknova (TKNO) Change in Receivables (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 7 years of Change in Receivables data on file, last reported at $1.1 million in Q1 2026.
- On a quarterly basis, Change in Receivables fell 21.35% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $86000.0, a 92.97% decrease from a year earlier, with the FY2025 full-year figure at $374000.0, down 24.29% from the prior year.
- Change in Receivables for Q1 2026 stood at $1.1 million, up from -$520000.0 in the prior quarter.
- Over the last five years, Change in Receivables for TKNO reached as high as $1.3 million in Q1 2025 and fell as low as -$1.3 million in Q4 2022.
- Historically, Change in Receivables has averaged $73941.2 across 5 years, with a median of $13000.0 in 2024.
- Across the five-year window, Change in Receivables tumbled 1330.56% in 2022 and jumped 277.09% in 2023, its largest moves.
- Year by year, Change in Receivables stood at -$1.3 million in 2022, then rose by 23.78% to -$1.0 million in 2023, then surged by 77.89% to -$224000.0 in 2024, then tumbled by 132.14% to -$520000.0 in 2025, then surged by 304.04% to $1.1 million in 2026.
- Per Business Quant data, the three most recent Change in Receivables figures were $1.1 million in Q1 2026, -$520000.0 in Q4 2025, and $17000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -78.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 106.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -621.82 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -38.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 126.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 81.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Alpha Teknova | 278.75 Mn | 260.97 Mn | 3.78 Mn | 1.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.06 Mn |
| Mar 31, 2026 | 1.06 Mn |
| Dec 31, 2025 | -520,000.00 |
| Dec 31, 2025 | -520,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Jun 30, 2025 | -472,000.00 |
| Jun 30, 2025 | -472,000.00 |
| Mar 31, 2025 | 1.35 Mn |
| Mar 31, 2025 | 1.35 Mn |
| Dec 31, 2024 | -224,000.00 |
| Dec 31, 2024 | -224,000.00 |
| Sep 30, 2024 | 13,000.00 |
| Sep 30, 2024 | 13,000.00 |
| Jun 30, 2024 | 86,000.00 |
| Jun 30, 2024 | 86,000.00 |
| Mar 31, 2024 | 619,000.00 |
| Mar 31, 2024 | 619,000.00 |
| Dec 31, 2023 | -1.01 Mn |
| Dec 31, 2023 | -1.01 Mn |